Neogen Co. (NASDAQ:NEOG) insider James L. Herbert sold 10,000 shares of the business’s stock in a transaction on Thursday, February 15th. The stock was sold at an average price of $57.50, for a total value of $575,000.00. Following the sale, the insider now directly owns 1,163,755 shares in the company, valued at $66,915,912.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of Neogen Co. (NEOG) opened at $59.79 on Monday. The stock has a market capitalization of $3,080.00, a price-to-earnings ratio of 59.79, a PEG ratio of 3.70 and a beta of 1.46. Neogen Co. has a 52-week low of $44.63 and a 52-week high of $64.42.
Neogen (NASDAQ:NEOG) last announced its earnings results on Wednesday, January 3rd. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.07. The company had revenue of $101.80 million for the quarter, compared to analyst estimates of $102.46 million. Neogen had a return on equity of 10.72% and a net margin of 13.47%. Neogen’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.29 earnings per share. equities research analysts predict that Neogen Co. will post 1.08 EPS for the current fiscal year.
Several hedge funds have recently modified their holdings of NEOG. Catalyst Capital Advisors LLC purchased a new position in shares of Neogen during the fourth quarter valued at $156,000. Bell Bank purchased a new position in shares of Neogen during the third quarter valued at $201,000. Parametrica Management Ltd purchased a new position in shares of Neogen during the third quarter valued at $202,000. Arcadia Investment Management Corp MI purchased a new position in shares of Neogen during the third quarter valued at $230,000. Finally, Stone Ridge Asset Management LLC purchased a new position in shares of Neogen during the fourth quarter valued at $241,000. Institutional investors and hedge funds own 65.58% of the company’s stock.
A number of equities research analysts have recently issued reports on NEOG shares. Roth Capital set a $62.00 target price on Neogen and gave the stock a “hold” rating in a research report on Thursday, January 4th. Zacks Investment Research raised Neogen from a “hold” rating to a “strong-buy” rating and set a $69.00 target price on the stock in a research report on Saturday, January 6th. Craig Hallum boosted their target price on Neogen from $46.50 to $60.00 and gave the stock a “hold” rating in a research report on Thursday, December 7th. BidaskClub raised Neogen from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Stephens reaffirmed a “hold” rating and set a $62.00 target price on shares of Neogen in a research report on Wednesday, January 10th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Neogen has a consensus rating of “Hold” and an average price target of $63.25.
TRADEMARK VIOLATION WARNING: This piece was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright law. The correct version of this piece can be read at https://ledgergazette.com/2018/02/19/insider-selling-neogen-co-neog-insider-sells-10000-shares-of-stock.html.
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.